Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice (original) (raw)
Lloyd KG, Davidson L, Hornykiewicz O (1975) The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther 195(3):453–464 CASPubMed Google Scholar
Gaki GS, Papavassiliou AG (2014) Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. NeuroMolecular Med. doi:10.1007/s12017-014-8294-x PubMed Google Scholar
Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism. Neurobiol Dis 51:35–42 ArticleCASPubMed Google Scholar
Tarazi FI, Sahli ZT, Wolny M, Mousa SA (2014) Emerging therapies for Parkinson's disease: from bench to bedside. Pharmacol Ther 144(2):123–133 ArticleCASPubMed Google Scholar
Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J et al (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59(10):1541–1550 ArticlePubMed Google Scholar
Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG (2014) Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim Biophys Acta 1842(8):1282–1294 ArticleCASPubMed Google Scholar
Oshiro S, Kawamura K, Zhang C, Sone T, Morioka MS, Kobayashi S, Nakajima K (2008) Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia. Biochim Biophys Acta 1782(2):109–117 ArticleCASPubMed Google Scholar
Teismann P, Schulz JB (2004) Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res 318(1):149–161 ArticlePubMed Google Scholar
Vargas MR, Johnson JA (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 11:e17 ArticlePubMed Google Scholar
Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62(6):649–671 ArticleCASPubMed Google Scholar
Sun X, Shih AY, Johannssen HC, Erb H, Li P, Murphy TH (2006) Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J Biol Chem 281(25):17420–17431 ArticleCASPubMed Google Scholar
Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci U S A 106(8):2933–2938 ArticleCASPubMedPubMed Central Google Scholar
Innamorato NG, Jazwa A, Rojo AI, Garcia C, Fernandez-Ruiz J, Grochot-Przeczek A, Stachurska A, Jozkowicz A et al (2010) Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS One 5(7):e11838 ArticlePubMedPubMed Central Google Scholar
Lastres-Becker I, Ulusoy A, Innamorato NG, Sahin G, Rabano A, Kirik D, Cuadrado A (2012) alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. Hum Mol Genet 21(14):3173–3192 ArticleCASPubMed Google Scholar
Gan L, Vargas MR, Johnson DA, Johnson JA (2012) Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci 32(49):17775–17787 ArticleCASPubMedPubMed Central Google Scholar
Dennery PA (2004) Introduction to serial review on heme oxygenase in human disease. Free Radic Biol Med 37(8):1095–1096 ArticleCASPubMed Google Scholar
Motterlini R, Foresti R (2014) Heme oxygenase-1 as a target for drug discovery. Antioxid Redox Signal 20(11):1810–1826 ArticleCASPubMed Google Scholar
Schipper HM, Liberman A, Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150(1):60–68 ArticleCASPubMed Google Scholar
Gerlach M, Riederer P, Przuntek H, Youdim MB (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol 208(4):273–286 ArticleCASPubMed Google Scholar
Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2(1):141–151 ArticleCASPubMed Google Scholar
Shi L, Bian X, Qu Z, Ma Z, Zhou Y, Wang K, Jiang H, Xie J (2013) Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. Nat Commun 4:1435 ArticlePubMed Google Scholar
Fernandez-Gonzalez A, Perez-Otano I, Morgan JI (2000) MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes. Eur J Neurosci 12(5):1573–1583 ArticleCASPubMed Google Scholar
Schipper HM (2004) Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann N Y Acad Sci 1012:84–93 ArticleCASPubMed Google Scholar
Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110(2):469–485 ArticleCASPubMed Google Scholar
Chung SW, Liu X, Macias AA, Baron RM, Perrella MA (2008) Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 118(1):239–247 ArticleCASPubMed Google Scholar
Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, Lee LY, Sobel RA et al (2007) Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117(2):438–447 ArticleCASPubMedPubMed Central Google Scholar
Zukor H, Song W, Liberman A, Mui J, Vali H, Fillebeen C, Pantopoulos K, Wu TD et al (2009) HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem 109(3):776–791 ArticleCASPubMed Google Scholar
Teng YC, Tai YI, Lee YH, Lin AM (2013) Role of HO-1 in the arsenite-induced neurotoxicity in primary cultured cortical neurons. Mol Neurobiol 48(2):281–287 ArticleCASPubMed Google Scholar
Jaremko KM, Chen-Roetling J, Chen L, Regan RF (2010) Accelerated hemolysis and neurotoxicity in neuron-glia-blood clot co-cultures. J Neurochem 114(4):1063–1073 CASPubMedPubMed Central Google Scholar
Gonzalez-Aparicio R, Blanco E, Serrano A, Pavon FJ, Parsons LH, Maldonado R, Robledo P, Fernandez-Espejo E et al (2014) The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism. Int J Neuropsychopharmacol 17(3):455–468 ArticleCASPubMed Google Scholar
Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernandez-Ruiz J, Cuadrado A (2011) Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal 14(12):2347–2360 ArticleCASPubMed Google Scholar
Cheng X, Ku CH, Siow RC (2013) Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis. Free Radic Biol Med 64:4–11 ArticleCASPubMed Google Scholar
Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G (2011) Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44(2):192–201 ArticleCASPubMed Google Scholar
Saleem S, Zhuang H, Biswal S, Christen Y, Dore S (2008) Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 39(12):3389–3396 ArticlePubMed Google Scholar
Kida K, Yamada M, Tokuda K, Marutani E, Kakinohana M, Kaneki M, Ichinose F (2011) Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal 15(2):343–352 ArticleCASPubMedPubMed Central Google Scholar
McGeer PL, McGeer EG (2008) Glial reactions in Parkinson's disease. Mov Disord 23(4):474–483 ArticlePubMed Google Scholar
Fernandez-Fernandez S, Almeida A, Bolanos JP (2012) Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem J 443(1):3–11 ArticleCASPubMed Google Scholar
McGann JC, Lioy DT, Mandel G (2012) Astrocytes conspire with neurons during progression of neurological disease. Curr Opin Neurobiol 22(5):850–858 ArticleCASPubMedPubMed Central Google Scholar
Heneka MT, Rodriguez JJ, Verkhratsky A (2010) Neuroglia in neurodegeneration. Brain Res Rev 63(1-2):189–211 ArticleCASPubMed Google Scholar
Halliday GM, Stevens CH (2011) Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord 26(1):6–17 ArticlePubMed Google Scholar
Hung SY, Liou HC, Fu WM (2010) The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression. Neuropharmacology 58(2):321–329 ArticleCASPubMed Google Scholar
Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, Fu WM (2008) Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol Pharmacol 74(6):1564–1575 ArticleCASPubMed Google Scholar
Dennery PA. Signaling function of heme oxygenase proteins. Antioxid Redox Signal. 2013
Tereshchenko J, Maddalena A, Bahr M, Kugler S (2014) Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease. Neurobiol Dis 65:35–42 ArticleCASPubMed Google Scholar
Chen SS, Yang C, Hao F, Li C, Lu T, Zhao LR, Duan WM (2014) Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism. Exp Neurol 261:87–96 ArticleCASPubMed Google Scholar
Wakeman DR, Redmond DE Jr, Dodiya HB, Sladek JR Jr, Leranth C, Teng YD, Samulski RJ, Snyder EY (2014) Human neural stem cells survive long term in the midbrain of dopamine-depleted monkeys after GDNF overexpression and project neurites toward an appropriate target. Stem Cells Transl Med 3(6):692–701 ArticleCASPubMedPubMed Central Google Scholar
Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, Ilan AB, Bulvik S et al (2009) Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev 18(8):1179–1190 ArticleCASPubMed Google Scholar
Liu WG, Wang XJ, Lu GQ, Li B, Wang G, Chen SD (2007) Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease. Mol Neurodegener 2:19 ArticlePubMedPubMed Central Google Scholar
Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV (2006) Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci 26(48):12497–12511 ArticleCASPubMed Google Scholar
Akerud P, Canals JM, Snyder EY, Arenas E (2001) Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J Neurosci 21(20):8108–8118 CASPubMed Google Scholar
Miyazaki I, Asanuma M, Murakami S, Takeshima M, Torigoe N, Kitamura Y, Miyoshi K (2013) Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models. Neurobiol Dis 59:244–256 ArticleCASPubMed Google Scholar